144 related articles for article (PubMed ID: 11863260)
1. Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans.
Nash JD; Burgess DS; Talbert RL
J Med Microbiol; 2002 Feb; 51(2):105-109. PubMed ID: 11863260
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans.
Chin NX; Weitzman I; Della-Latta P
Antimicrob Agents Chemother; 1997 Apr; 41(4):850-2. PubMed ID: 9087504
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluconazole on plasma fluvastatin and pravastatin concentrations.
Kantola T; Backman JT; Niemi M; Kivistö KT; Neuvonen PJ
Eur J Clin Pharmacol; 2000 Jun; 56(3):225-9. PubMed ID: 10952477
[TBL] [Abstract][Full Text] [Related]
4. EPR studies on hydroxyl radical-scavenging activities of pravastatin and fluvastatin.
Vandjelovic N; Zhu H; Misra HP; Zimmerman RP; Jia Z; Li Y
Mol Cell Biochem; 2012 May; 364(1-2):71-7. PubMed ID: 22207075
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of fluvastatin on ileal ulcer formation in rats induced by nonsteroidal antiinflammatory drug.
Hagiwara M; Kataoka K; Arimochi H; Kuwahara T; Nakayama H; Ohnishi Y
World J Gastroenterol; 2005 Feb; 11(7):1040-3. PubMed ID: 15742411
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.
Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Weitz-Schmidt G; Nishibori M
J Leukoc Biol; 2005 Mar; 77(3):400-7. PubMed ID: 15618295
[TBL] [Abstract][Full Text] [Related]
7. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Bozó A; Domán M; Majoros L; Kardos G; Varga I; Kovács R
J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932
[TBL] [Abstract][Full Text] [Related]
8. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
[TBL] [Abstract][Full Text] [Related]
9. Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans.
Yang DL; Hu YL; Yin ZX; Zeng GS; Li D; Zhang YQ; Xu ZH; Guan XM; Weng LX; Wang LH
Biomed Environ Sci; 2019 Mar; 32(3):199-209. PubMed ID: 30987694
[TBL] [Abstract][Full Text] [Related]
10. Effect of 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors (statins) on tissue paraoxonase 1 and plasma platelet activating factor acetylhydrolase activities.
Bełtowski J; Wójcicka G; Jamroz A
J Cardiovasc Pharmacol; 2004 Jan; 43(1):121-7. PubMed ID: 14668577
[TBL] [Abstract][Full Text] [Related]
11. [Effect of Huanglian Jiedu decoction in combination with fluconazole on ergosterol of fluconazole-resistant Candida albicans].
Yan YY; Wang TM; Shi GX; Zhang MX; Lu KQ; Shao J; Wang CZ
Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):727-32. PubMed ID: 26137698
[TBL] [Abstract][Full Text] [Related]
12. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
13. Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans.
Premachandra ID; Scott KA; Shen C; Wang F; Lane S; Liu H; Van Vranken DL
ChemMedChem; 2015 Oct; 10(10):1672-86. PubMed ID: 26263912
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy.
Ogata Y; Takahashi M; Takeuchi K; Ueno S; Mano H; Ookawara S; Kobayashi E; Ikeda U; Shimada K
J Cardiovasc Pharmacol; 2002 Dec; 40(6):907-15. PubMed ID: 12451324
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
Sun L; Liao K; Hang C
Phytomedicine; 2018 Feb; 40():55-58. PubMed ID: 29496175
[TBL] [Abstract][Full Text] [Related]
16. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes.
Yamamoto A; Hoshi K; Ichihara K
Eur J Pharmacol; 1998 Nov; 361(1):143-9. PubMed ID: 9851551
[TBL] [Abstract][Full Text] [Related]
17. Are the Statins promising antifungal agents against invasive candidiasis?
Lima WG; Alves-Nascimento LA; Andrade JT; Vieira L; de Azambuja Ribeiro RIM; Thomé RG; Dos Santos HB; Ferreira JMS; Soares AC
Biomed Pharmacother; 2019 Mar; 111():270-281. PubMed ID: 30590315
[TBL] [Abstract][Full Text] [Related]
18. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole.
Huang S; Cao YY; Dai BD; Sun XR; Zhu ZY; Cao YB; Wang Y; Gao PH; Jiang YY
Biol Pharm Bull; 2008 Dec; 31(12):2234-6. PubMed ID: 19043205
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y
J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
